Breaking News

Yesterday Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
Hot Stocks	Gamida publishes results of trial to evaluate omidubicel for stem cell treatment » 07:06 06/23/21 06/23 07:06 06/23/21 07:06 GMDA Gamida Cell $6.05 / -0.01 (-0.17%) Gamida Cell announced… Gamida Cell announced that the results of a Phase 3 clinical study of omidubicel have been published in Blood, the official journal of the American Society of Hematology. Omidubicel is an advanced cell therapy under development as a potential life-saving allogeneic hematopoietic stem cell transplant solution for patients with hematologic malignancies. The results demonstrate that transplantation with omidubicel leads to faster neutrophil and platelet recovery compared to a standard umbilical cord blood graft, and results in fewer early bacterial and viral infections and less time in the hospital. "We are pleased that the data from this well-conducted international Phase 3 trial have been published in Blood, the highly respected, peer-reviewed journal of the American Society of Hematology," said Ronit Simantov, ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options GMDA Gamida Cell $6.05 / -0.01 (-0.17%) 03/15/21 Gamida Cell presents efficacy results from Phase 3 omidubicel study 02/09/21 Gamida Cell says phase 3 results show faster hematopoietic recovery 01/11/21 Gamida Cell to present full data from Phase 3 study of omidubicel at TCT meeting GMDA Gamida Cell $6.05 / -0.01 (-0.17%) 05/11/21 Oppenheimer Gamida Cell progressing toward omidubicel BLA, says Oppenheimer 05/11/21 JMP Securities JMP Securities bullish on Gamida Cell, says regulatory preparedness on track 03/09/21 Piper Sandler Gamida Cell price target lowered to $23 from $25 at Piper Sandler 02/10/21 H.C. Wainwright Gamida Cell price target raised to $27 from $15 at H.C. Wainwright GMDA Gamida Cell $6.05 / -0.01 (-0.17%) 05/11/21 Gamida Cell reports Q1EPS 34c, consensus (40c) GMDA Gamida Cell $6.05 / -0.01 (-0.17%) 02/10/21 Fly Intel: Wall Street's top stories for Wednesday 02/10/21 Fly Intel: Wall Street's top stories at midday 02/10/21 Fly Intel: Pre-market Movers GMDA Gamida Cell $6.05 / -0.01 (-0.17%) 01/19/21 Nine new option listings and thirteen option delistings on January 19th

Over a month ago
Recommendations	Gamida Cell progressing toward omidubicel BLA, says Oppenheimer » 20:27 05/11/21 05/11 20:27 05/11/21 20:27 GMDA Gamida Cell $6.83 / +0.04 (+0.59%) Oppenheimer analyst Mark… Oppenheimer analyst Mark Breidenbach keeps his Outperform rating and $17 price target on Gamida Cell after its Q1 results. The analyst states that his follow-up conversations with the management suggest that the company is making progress toward completing omidubicel's BLA and still expects to file in Q4. The company has adequate cash to sustain operations into the second half of next year, Breidenbach adds. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options GMDA Gamida Cell $6.83 / +0.04 (+0.59%) 03/15/21 Gamida Cell presents efficacy results from Phase 3 omidubicel study 02/09/21 Gamida Cell says phase 3 results show faster hematopoietic recovery 01/11/21 Gamida Cell to present full data from Phase 3 study of omidubicel at TCT meeting 12/14/20 FDA asks Gamida Cell for more manufacturing-related data for pre-BLA GMDA Gamida Cell $6.83 / +0.04 (+0.59%) 05/11/21 JMP Securities JMP Securities bullish on Gamida Cell, says regulatory preparedness on track 03/09/21 Piper Sandler Gamida Cell price target lowered to $23 from $25 at Piper Sandler 02/10/21 H.C. Wainwright Gamida Cell price target raised to $27 from $15 at H.C. Wainwright 02/09/21 Piper Sandler Gamida Cell price target raised to $25 from $13 at Piper Sandler GMDA Gamida Cell $6.83 / +0.04 (+0.59%) 05/11/21 Gamida Cell reports Q1EPS 34c, consensus (40c) 19 May GMDA Gamida Cell $6.83 / +0.04 (+0.59%) 02/10/21 Fly Intel: Wall Street's top stories for Wednesday 02/10/21 Fly Intel: Wall Street's top stories at midday 02/10/21 Fly Intel: Pre-market Movers 12/07/20 Fly Intel: Wall Street's top stories for Monday 05/11/21 Gamida Cell - GMDA GMDA Gamida Cell $6.83 / +0.04 (+0.59%) 01/19/21 Nine new option listings and thirteen option delistings on January 19th
Recommendations	JMP Securities bullish on Gamida Cell, says regulatory preparedness on track » 11:15 05/11/21 05/11 11:15 05/11/21 11:15 GMDA Gamida Cell $6.72 / -0.07 (-1.03%) JMP Securities analyst… JMP Securities analyst Jason Butler reiterates an Outperform rating on Gamida Cell, with a price target of $19, after the company reported Q1 earnings ahead of expectations on lower-than-expected operating expenses. The analyst also highlights solid execution toward key 2021 milestones with omidubicel BLA submission on track for Q4 2021 and GDA-201 IND submission still expected in the second half of 2021. Commercial manufacturing activities are advancing well, and continue to support a BLA submission in Q4 2021, as the company is completing manufacturing comparability with its commercial sites and clinical supply, he adds. Butler remains "enthusiastic" about the differentiated clinical benefits demonstrated by omidubicel in the Phase 2 and 3 trials, the unmet need that the candidate addresses, and its commercial potential. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options GMDA Gamida Cell $6.72 / -0.07 (-1.03%) 03/15/21 Gamida Cell presents efficacy results from Phase 3 omidubicel study 02/09/21 Gamida Cell says phase 3 results show faster hematopoietic recovery 01/11/21 Gamida Cell to present full data from Phase 3 study of omidubicel at TCT meeting 12/14/20 FDA asks Gamida Cell for more manufacturing-related data for pre-BLA GMDA Gamida Cell $6.72 / -0.07 (-1.03%) 03/09/21 Piper Sandler Gamida Cell price target lowered to $23 from $25 at Piper Sandler 02/10/21 H.C. Wainwright Gamida Cell price target raised to $27 from $15 at H.C. Wainwright 02/09/21 Piper Sandler Gamida Cell price target raised to $25 from $13 at Piper Sandler 12/14/20 Oppenheimer Gamida Cell price target lowered to $17 from $20 at Oppenheimer GMDA Gamida Cell $6.72 / -0.07 (-1.03%) 05/11/21 Gamida Cell reports Q1EPS 34c, consensus (40c) 19 May GMDA Gamida Cell $6.72 / -0.07 (-1.03%) 02/10/21 Fly Intel: Wall Street's top stories for Wednesday 02/10/21 Fly Intel: Wall Street's top stories at midday 02/10/21 Fly Intel: Pre-market Movers 12/07/20 Fly Intel: Wall Street's top stories for Monday 05/11/21 Gamida Cell - GMDA GMDA Gamida Cell $6.72 / -0.07 (-1.03%) 01/19/21 Nine new option listings and thirteen option delistings on January 19th
Earnings	Gamida Cell reports Q1EPS 34c, consensus (40c) » 07:05 05/11/21 05/11 07:05 05/11/21 07:05 GMDA Gamida Cell $6.75 / -0.07 (-1.03%) As of March 31, 2021,… As of March 31, 2021, Gamida Cell had total cash and cash equivalents of $174.8 million, compared to $127.2 million as of December 31, 2020. "In the first quarter of this year, we made significant progress on key initiatives across all functions of our business, starting with omidubicel, a potentially transformative treatment option for patients with hematological malignancies," said Julian Adams, Ph.D., chief executive officer of Gamida Cell. "We are working diligently to bring this novel therapy to patients, with submission of a BLA to the FDA anticipated in the fourth quarter of this year. We are progressing well with our manufacturing readiness activities in response to the clear feedback from the FDA regarding registration of our commercial manufacturing facilities and are actively building our launch readiness capabilities, including market access and support services, to ensure a positive patient experience at transplant at the time of potential FDA approval." ShowHide Related Items >><< Company News Street Research Syndicate On The Fly Events Options GMDA Gamida Cell $6.75 / -0.07 (-1.03%) 03/15/21 Gamida Cell presents efficacy results from Phase 3 omidubicel study 02/09/21 Gamida Cell says phase 3 results show faster hematopoietic recovery 01/11/21 Gamida Cell to present full data from Phase 3 study of omidubicel at TCT meeting 12/14/20 FDA asks Gamida Cell for more manufacturing-related data for pre-BLA GMDA Gamida Cell $6.75 / -0.07 (-1.03%) 03/09/21 Piper Sandler Gamida Cell price target lowered to $23 from $25 at Piper Sandler 02/10/21 H.C. Wainwright Gamida Cell price target raised to $27 from $15 at H.C. Wainwright 02/09/21 Piper Sandler Gamida Cell price target raised to $25 from $13 at Piper Sandler 12/14/20 Oppenheimer Gamida Cell price target lowered to $17 from $20 at Oppenheimer 19 May GMDA Gamida Cell $6.75 / -0.07 (-1.03%) 02/10/21 Fly Intel: Wall Street's top stories for Wednesday 02/10/21 Fly Intel: Wall Street's top stories at midday 02/10/21 Fly Intel: Pre-market Movers 12/07/20 Fly Intel: Wall Street's top stories for Monday 05/11/21 Gamida Cell - GMDA GMDA Gamida Cell $6.75 / -0.07 (-1.03%) 01/19/21 Nine new option listings and thirteen option delistings on January 19th

Over a quarter ago
Hot Stocks	Gamida Cell presents efficacy results from Phase 3 omidubicel study » 10:25 03/15/21 03/15 10:25 03/15/21 10:25 GMDA Gamida Cell $8.93 / +0.05 (+0.56%) Gamida Cell Ltd.… Gamida Cell Ltd. announced the results of a Phase 3 clinical study of omidubicel presented in an oral session at the Presidential Symposium of the 47th Annual Meeting of the European Society for Blood and Marrow Transplantation. In addition to the Presidential Symposium, the session will be featured in a live panel discussion, "EBMT Talks: Live with the Best Abstracts." This clinical data set, which was also recently presented at the Transplantation & Cellular Therapy Meetings of the American Society of Transplantation and Cellular Therapy and Center for International Blood & Marrow Transplant Research, or the TCT Meetings, was from the international, multi-center, randomized Phase 3 study of omidubicel designed to evaluate the safety and efficacy of omidubicel in patients with high-risk hematologic malignancies undergoing a bone marrow transplant compared to patients who received a standard umbilical cord blood transplant. Gamida Cell previously reported in May 2020 that the study achieved its primary endpoint, showing that omidubicel demonstrated a statistically significant reduction in time to neutrophil engraftment, a measure of how quickly the stem cells a patient receives in a transplant are established and begin to make healthy new cells, and a key milestone in a patient's recovery from a bone marrow transplant. The median time to neutrophil engraftment was 12 days for patients randomized to omidubicel compared to 22 days for the comparator group. All three secondary endpoints demonstrated a statistically significant improvement among patients who were randomized to omidubicel in relation to patients randomized to the comparator group. Platelet engraftment was significantly accelerated with omidubicel, with 55 percent of patients randomized to omidubicel achieving platelet engraftment at day 42, compared to 35 percent for the comparator. The rate of infection was significantly reduced for patients randomized to omidubicel, with the cumulative incidence of first grade 2 or grade 3 bacterial or invasive fungal infection for patients randomized to omidubicel of 37 percent, compared to 57 percent for the comparator. Hospitalization in the first 100 days after transplant was also reduced in patients randomized to omidubicel, with a median number of days alive and out of hospital for patients randomized to omidubicel of 60.5 days, compared to 48.0 days for the comparator. The details of these data were first reported in December 2020. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options GMDA Gamida Cell $8.93 / +0.05 (+0.56%) 02/09/21 Gamida Cell says phase 3 results show faster hematopoietic recovery 01/11/21 Gamida Cell to present full data from Phase 3 study of omidubicel at TCT meeting 12/14/20 FDA asks Gamida Cell for more manufacturing-related data for pre-BLA 12/09/20 Gamida Cell provides achieves all three secondary endpoints of omidubicel study GMDA Gamida Cell $8.93 / +0.05 (+0.56%) 03/09/21 Piper Sandler Gamida Cell price target lowered to $23 from $25 at Piper Sandler 02/10/21 H.C. Wainwright Gamida Cell price target raised to $27 from $15 at H.C. Wainwright 02/09/21 Piper Sandler Gamida Cell price target raised to $25 from $13 at Piper Sandler 12/14/20 Oppenheimer Gamida Cell price target lowered to $17 from $20 at Oppenheimer GMDA Gamida Cell $8.93 / +0.05 (+0.56%) 11/10/20 Gamida Cell reports Q3 EPS (30c), consensus (31c) 19 May GMDA Gamida Cell $8.93 / +0.05 (+0.56%) 02/10/21 Fly Intel: Wall Street's top stories for Wednesday 02/10/21 Fly Intel: Wall Street's top stories at midday 02/10/21 Fly Intel: Pre-market Movers 12/07/20 Fly Intel: Wall Street's top stories for Monday 03/17/21 31st Annual Healthcare Virtual Conference GMDA Gamida Cell $8.93 / +0.05 (+0.56%) 01/19/21 Nine new option listings and thirteen option delistings on January 19th

Recommendations	Gamida Cell price target lowered to $23 from $25 at Piper Sandler » 12:18 03/09/21 03/09 12:18 03/09/21 12:18 GMDA Gamida Cell $8.35 / +0.19 (+2.33%) Piper Sandler analyst… Piper Sandler analyst Edward Tenthoff lowered the firm's price target on Gamida Cell to $23 from $25 and keeps an Overweight rating on the shares. With the Highbridge convertible note, Tenthoff estimates Gamida Cell holds pro forma cash of ~$202M, which will fund operations into the second half of 2022, the analyst tells investors in a research note. Gamida Cell expects to file an IND for GDA-201 and initiate a Phase I/II study in DLBCL and follicular lymphoma in 2H21, the analyst adds. ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options GMDA Gamida Cell $8.35 / +0.19 (+2.33%) 02/09/21 Gamida Cell says phase 3 results show faster hematopoietic recovery 01/11/21 Gamida Cell to present full data from Phase 3 study of omidubicel at TCT meeting 12/14/20 FDA asks Gamida Cell for more manufacturing-related data for pre-BLA 12/09/20 Gamida Cell provides achieves all three secondary endpoints of omidubicel study GMDA Gamida Cell $8.35 / +0.19 (+2.33%) 02/10/21 H.C. Wainwright Gamida Cell price target raised to $27 from $15 at H.C. Wainwright 02/09/21 Piper Sandler Gamida Cell price target raised to $25 from $13 at Piper Sandler 12/14/20 Oppenheimer Gamida Cell price target lowered to $17 from $20 at Oppenheimer 12/14/20 Piper Sandler Gamida Cell delay does not impact peak sales, says Piper Sandler GMDA Gamida Cell $8.35 / +0.19 (+2.33%) 11/10/20 Gamida Cell reports Q3 EPS (30c), consensus (31c) 19 May GMDA Gamida Cell $8.35 / +0.19 (+2.33%) 02/10/21 Fly Intel: Wall Street's top stories for Wednesday 02/10/21 Fly Intel: Wall Street's top stories at midday 02/10/21 Fly Intel: Pre-market Movers 12/07/20 Fly Intel: Wall Street's top stories for Monday 03/09/21 Gamida Cell - GMDA GMDA Gamida Cell $8.35 / +0.19 (+2.33%) 01/19/21 Nine new option listings and thirteen option delistings on January 19th
Syndicate	Gamida Cell files to sell 6.33M ordinary shares for holders 16:41 03/01/21 03/01 16:41 03/01/21 16:41 GMDA Gamida Cell $9.86 / +0.46 (+4.89%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options GMDA Gamida Cell $9.86 / +0.46 (+4.89%) 02/09/21 Gamida Cell says phase 3 results show faster hematopoietic recovery 01/11/21 Gamida Cell to present full data from Phase 3 study of omidubicel at TCT meeting 12/14/20 FDA asks Gamida Cell for more manufacturing-related data for pre-BLA 12/09/20 Gamida Cell provides achieves all three secondary endpoints of omidubicel study GMDA Gamida Cell $9.86 / +0.46 (+4.89%) 02/10/21 H.C. Wainwright Gamida Cell price target raised to $27 from $15 at H.C. Wainwright 02/09/21 Piper Sandler Gamida Cell price target raised to $25 from $13 at Piper Sandler 12/14/20 Oppenheimer Gamida Cell price target lowered to $17 from $20 at Oppenheimer 12/14/20 Piper Sandler Gamida Cell delay does not impact peak sales, says Piper Sandler GMDA Gamida Cell $9.86 / +0.46 (+4.89%) 11/10/20 Gamida Cell reports Q3 EPS (30c), consensus (31c) 19 May GMDA Gamida Cell $9.86 / +0.46 (+4.89%) 02/10/21 Fly Intel: Wall Street's top stories for Wednesday 02/10/21 Fly Intel: Wall Street's top stories at midday 02/10/21 Fly Intel: Pre-market Movers 12/07/20 Fly Intel: Wall Street's top stories for Monday GMDA Gamida Cell $9.86 / +0.46 (+4.89%) 01/19/21 Nine new option listings and thirteen option delistings on January 19th
On The Fly	Fly Intel: Wall Street's top stories for Wednesday » 16:43 02/10/21 02/10 16:43 02/10/21 16:43 AKAM Akamai $105.09 / -12.92 (-10.95%) , CSCO Cisco $47.25 / -1.19 (-2.46%) , KO Coca-Cola $49.60 / -0.09 (-0.18%) , GM General Motors $54.87 / -1.2 (-2.14%) , TWTR Twitter $67.78 / +7.88 (+13.16%) , TEVA Teva $11.92 / -0.9 (-7.02%) , MTCH Match Group $171.00 / +11.97 (+7.53%) , WMT Walmart $144.13 / -1.68 (-1.15%) , ORCL Oracle $63.27 / -0.4 (-0.63%) , FB Facebook $271.90 / +2.36 (+0.88%) , GMDA Gamida Cell $12.41 / +2.49 (+25.10%) , LYFT Lyft $56.15 / +2.56 (+4.78%) , YELP Yelp $36.82 / -1.74 (-4.51%) , MAT Mattel $18.49 / -0.34 (-1.81%) The major averages had a… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options YELP WMT TWTR TEVA ORCL MTCH MAT LYFT KO GMDA GM FB CSCO AKAM YELP Yelp $36.82 / -1.74 (-4.51%) 02/09/21 Yelp expects to return to sustainable revenue growth in 2021 01/12/21 Yelp to display user feedback on health, safety practices of businesses 12/27/20 Fly Intel: Top five weekend stock stories 12/04/20 D. E. Shaw & Co. reports 5% passive stake in Yelp WMT Walmart $144.13 / -1.68 (-1.15%) 02/10/21 White House says potential TikTok deal still being reviewed 02/10/21 Jim Cramer says WSJ report of shelved TikTok sale not accurate 02/08/21 TikTok, Universal Music Group announce expanded global alliance 02/02/21 Walmart and Sam's Club pharmacies to administer COVID vaccine in federal program TWTR Twitter $67.78 / +7.88 (+13.16%) 02/10/21 Twitter CFO to CNBC's 'Squawk Box': Company has studied using bitcoin 02/10/21 Twitter suspends 500 accounts in India after government serves blocking orders 02/09/21 Twitter to reset growth benchmarks after pandemic ebbs 02/09/21 Twitter maintaining investment posture in 2021 TEVA Teva $11.92 / -0.9 (-7.02%) 02/10/21 Teva says 'optimistic' about opioid settlement, but 'not optimistic' on timeline 02/10/21 Teva targets 28% operating margin by end of 2023 02/10/21 Teva says 'very optimistic' about biosimilar pipeline 01/29/21 Teva's BroPair Spiromax gets positive recommendation from EMA's CHMP ORCL Oracle $63.27 / -0.4 (-0.63%) 01/14/21 Microsoft, Oracle, Salseforce, others form Vaccination Credential Initiative MTCH Match Group $171.00 / +11.97 (+7.53%) 02/09/21 Match Group to acquire Hyperconnect for $1.725B in cash and stock 02/09/21 Match Group to acquire Hyperconnect for $1.725B in cash and stock 12/07/20 Match Group, RAINN enter partnership for dating safety 11/04/20 Match Group says future remains 'challenging to predict' MAT Mattel $18.49 / -0.34 (-1.81%) 02/09/21 Mattel implementing new 'Optimizing for Growth' program 12/08/20 Mattel names Jonathan Anschell chief legal officer 12/03/20 Mattel enters licensing agreement with PGS Entertainment for toys based on show 10/23/20 Mattel CEO: Our strategy is clearly working LYFT Lyft $56.15 / +2.56 (+4.78%) 02/09/21 Lyft jumps 5% to $56.50 per share after Q4 results 02/09/21 Lyft reports Q4 active riders 12,552, down 45.2% 01/22/21 Lyft urges vaccination officials to allow access for mobility-challenged KO Coca-Cola $49.60 / -0.09 (-0.18%) 02/10/21 Coca-Cola believes tax court 'misinterpreted and misapplied' in conclusions 02/10/21 Coca-Cola sees FY21 adjusted EPS 'at or above 2019 levels' 02/10/21 Coca-Cola sees improvement in business as vaccinations become widely available 02/10/21 Coca-Cola: Resolution in IRS tax dispute 'likely to take some time' GMDA Gamida Cell $12.41 / +2.49 (+25.10%) 02/09/21 Gamida Cell says phase 3 results show faster hematopoietic recovery 01/11/21 Gamida Cell to present full data from Phase 3 study of omidubicel at TCT meeting 12/14/20 FDA asks Gamida Cell for more manufacturing-related data for pre-BLA 12/09/20 Gamida Cell provides achieves all three secondary endpoints of omidubicel study GM General Motors $54.87 / -1.2 (-2.14%) 02/10/21 GM has no plans to invest in bitcoin 02/10/21 General Motors not commenting on dividend until 'later in the year' 02/10/21 GM not planning to partner with rideshare players as EV portfolio rolls out 02/10/21 General Motors sees 2H21 stronger than 1H21 FB Facebook $271.90 / +2.36 (+0.88%) 02/08/21 Facebook to expand efforts to remove false COVID-19 claims from platforms 02/02/21 Instagram launches Recently Deleted feature 01/31/21 Fly Intel: Top five weekend stock stories 01/28/21 Facebook's Oversight Board overturns four decisions, upholds one CSCO Cisco $47.25 / -1.19 (-2.46%) 02/09/21 Cisco falls over 3% to $47 per share after Q2 earnings, Q3 guidance 02/09/21 Cisco increases quarterly dividend 3% to 37c per share 02/09/21 Cisco seeing 'encouraging signs of strength' across business 02/09/21 Cisco reports Q2 product sales $8.57B, service sales $3.39B AKAM Akamai $105.09 / -12.92 (-10.95%) 02/09/21 Akamai drops 6% to $110.70 after Q4 results, FY guidance 02/09/21 Akamai says expects to see traffic continue to grow in 2021 02/09/21 Akamai CEO says strong Q4 performance 'capped off an excellent year' 02/09/21 Akamai announces organizational realignment AKAM CSCO KO GM TWTR TEVA MTCH WMT ORCL FB GMDA LYFT YELP MAT AKAM Akamai $105.09 / -12.92 (-10.95%) 02/10/21 Fly Intel: Top five analyst downgrades 02/10/21 Craig-Hallum Akamai downgraded to Hold at Craig-Hallum 02/10/21 Credit Suisse Akamai price target raised to $115 from $105 at Credit Suisse 02/10/21 Craig-Hallum Akamai downgraded to Hold from Buy at Craig-Hallum CSCO Cisco $47.25 / -1.19 (-2.46%) 02/11/21 DZ Bank Cisco upgraded to Buy from Hold at DZ Bank 02/10/21 Evercore ISI Cisco trends 'slowly but steadily inflecting higher,' says Evercore ISI 02/10/21 Citi Cisco price target raised to $50 from $45 at Citi 02/10/21 Piper Sandler Cisco price target raised to $47 from $45 at Piper Sandler KO Coca-Cola $49.60 / -0.09 (-0.18%) 01/19/21 Bernstein Coca-Cola initiated with an Outperform at Bernstein 01/13/21 HSBC Coca-Cola price target lowered to $58 from $61 at HSBC 01/07/21 Fly Intel: Top five analyst downgrades 01/07/21 JPMorgan Coca-Cola downgraded to Neutral on tax risks at JPMorgan GM General Motors $54.87 / -1.2 (-2.14%) 02/11/21 RBC Capital General Motors price target raised to $67 from $52 at RBC Capital 02/09/21 Barclays General Motors price target raised to $64 from $56 at Barclays 02/01/21 Wedbush Nikola upgraded to Neutral from Underperform at Wedbush 01/29/21 Morgan Stanley General Motors price target raised to $80 from $57 at Morgan Stanley TWTR Twitter $67.78 / +7.88 (+13.16%) 02/10/21 MoffettNathanson Twitter upgraded to Neutral from Sell at MoffettNathanson 02/10/21 KeyBanc Twitter price target raised to $80 from $65 at KeyBanc 02/10/21 Oppenheimer Twitter price target raised to $70 from $58 at Oppenheimer 02/10/21 Wedbush Twitter price target raised to $56.50 from $47 at Wedbush TEVA Teva $11.92 / -0.9 (-7.02%) 01/26/21 Piper Sandler Amarin in 'strong position' against Health Net, says Piper Sandler 12/21/20 Gabelli Teva named 'Best Idea for 2021' at Gabelli 11/27/20 H.C. Wainwright Corcept Therapeutics price target raised to $32 from $22 at H.C. Wainwright 11/24/20 Oppenheimer Teva initiated with a Perform at Oppenheimer MTCH Match Group $171.00 / +11.97 (+7.53%) 02/10/21 Wedbush Match Group price target raised to $150 from $135 at Wedbush 02/05/21 Citi Match Group price target raised to $175 from $160 at Citi 02/04/21 Fly Intel: Top five analyst upgrades 02/04/21 Match Group upgraded to Overweight on earnings pullback at JPMorgan WMT Walmart $144.13 / -1.68 (-1.15%) 02/09/21 Jefferies Dollar General well-positioned to mitigate minimum wage headwind, says Jefferies 01/29/21 Jefferies Carvana, Walmart among 13 additions to Jefferies Franchise Picks list 01/25/21 Fly Intel: Top five analyst downgrades 01/25/21 R5 Capital R5 Capital downgrades 'operationally challenged' Walmart to Sell ORCL Oracle $63.27 / -0.4 (-0.63%) 01/21/21 Goldman Sachs Oracle initiated with a Sell at Goldman Sachs 12/18/20 Fly Intel: Top five analyst upgrades 12/18/20 Monness Crespi Monness Crespi upgrades 'value play' Oracle to Buy with $82 price target 12/18/20 Monness Crespi Oracle upgraded to Buy from Neutral at Monness Crespi FB Facebook $271.90 / +2.36 (+0.88%) 02/10/21 Tigress Financial Facebook has 'significant upside' at current levels, says Tigress 02/01/21 Truist Alphabet price target raised to $2,100 from $2,000 at Truist 01/31/21 Citi Facebook price target raised to $320 from $315 at Citi 01/28/21 KeyBanc Facebook price target raised to $360 from $345 at KeyBanc GMDA Gamida Cell $12.41 / +2.49 (+25.10%) 02/10/21 H.C. Wainwright Gamida Cell price target raised to $27 from $15 at H.C. Wainwright 02/09/21 Piper Sandler Gamida Cell price target raised to $25 from $13 at Piper Sandler 12/14/20 Oppenheimer Gamida Cell price target lowered to $17 from $20 at Oppenheimer 12/14/20 Piper Sandler Gamida Cell delay does not impact peak sales, says Piper Sandler LYFT Lyft $56.15 / +2.56 (+4.78%) 02/11/21 KeyBanc Uber price target raised to $75 from $63 at KeyBanc 02/11/21 Needham Needham transfers coverage on Lyft, raises price target $70 from $50 02/10/21 DA Davidson Lyft price target raised to $66 from $58 at DA Davidson 02/10/21 Jefferies Lyft price target raised to $75 from $70 at Jefferies YELP Yelp $36.82 / -1.74 (-4.51%) 02/10/21 Truist Yelp price target raised to $40 from $30 at Truist 02/10/21 Credit Suisse Yelp price target raised to $41 from $35 at Credit Suisse 02/10/21 Wedbush Yelp price target raised to $38 from $30 at Wedbush 02/10/21 UBS Yelp price target raised to $40 from $30 at UBS MAT Mattel $18.49 / -0.34 (-1.81%) 02/10/21 KeyBanc Mattel price target raised to $22 from $17 at KeyBanc 12/09/20 Citi Mattel initiated with a Neutral at Citi 11/09/20 Fly Intel: Top five analyst downgrades 11/09/20 Jefferies Jefferies downgrades Mattel to Hold as stock nears $15 price target YELP WMT TWTR TEVA ORCL MTCH MAT LYFT KO GMDA GM FB CSCO AKAM YELP Yelp $36.82 / -1.74 (-4.51%) 02/09/21 Yelp sees FY21 net revenue $985M-$1.005B, consensus $979.22M 02/09/21 Yelp reports Q4 EPS 27c, consensus 27c 11/05/20 Yelp sees Q4 revenue $220M-$230M, consensus $226.22M WMT Walmart $144.13 / -1.68 (-1.15%) 11/17/20 Walmart reports Q3 adjusted EPS $1.34, consensus $1.18 11/16/20 Notable companies reporting before tomorrow's open 08/18/20 Walmart reports Q2 adjusted EPS $1.56, consensus $1.25 TWTR Twitter $67.78 / +7.88 (+13.16%) 02/09/21 Twitter sees Q1 revenue $940M-$1.04B, consensus $965.14M 02/09/21 Twitter reports Q4 adjusted EPS 38c, consensus 31c 10/29/20 Twitter reports Q3 adjusted EPS 19c, consensus 6c TEVA Teva $11.92 / -0.9 (-7.02%) 02/10/21 Teva sees Q1 lowest for EPS, sales in FY21 02/10/21 Teva sees FY21 EBITDA $4.8B-$5.1B 02/10/21 Teva sees FY21 EPS $2.50-$2.70, consensus $2.63 02/10/21 Teva reports Q4 EPS 68c, consensus 63c ORCL Oracle $63.27 / -0.4 (-0.63%) 12/10/20 Oracle sees Q3 revenue up 1%-3% in constant FX, up 2%-4% in USD 12/10/20 Oracle sees Q3 EPS up 10%-14% to $1.06-$1.10 at constant FX, consensus $1.04 12/10/20 Oracle reports Q2 adjusted EPS $1.06, consensus $1.00 12/10/20 Notable companies reporting after market close MTCH Match Group $171.00 / +11.97 (+7.53%) 02/02/21 Match Group sees Q1 revenue of $645M-$655M, consensus $646.6M 02/02/21 Match Group sees FY21 revenue $2.75B-$2.85B, consensus $2.84B 02/02/21 Match Group reports Q4 EPS 48c, consensus 49c 02/02/21 Notable companies reporting after market close MAT Mattel $18.49 / -0.34 (-1.81%) 02/09/21 Mattel sees FY21 adjusted EBITDA $775M-$800M vs. $719M last year 02/09/21 Mattel reports Q4 adjusted EPS 40c, consensus 23c 10/22/20 Mattel sees 'strong' adjusted EBITDA growth for FY20 vs. FY19 LYFT Lyft $56.15 / +2.56 (+4.78%) 02/09/21 Lyft reports Q4 revenue $569.9M, consensus $562.49M 12/02/20 Lyft sees Q4 sequential revenue growth at lower end of 11%-15% range 11/10/20 Lyft reports Q3 adj. EPS (89c), consensus (91c) KO Coca-Cola $49.60 / -0.09 (-0.18%) 02/10/21 Coca-Cola says Q1 adjusted EPS to include an approximate 2% currency headwind 02/10/21 Coca-Cola sees FY21 adjusted EPS growth high single digits to low double digits 02/10/21 Coca-Cola reports Q4 adjusted EPS 47c, consensus 42c 02/09/21 Notable companies reporting before tomorrow's open GMDA Gamida Cell $12.41 / +2.49 (+25.10%) 11/10/20 Gamida Cell reports Q3 EPS (30c), consensus (31c) 08/11/20 Gamida Cell reports Q2 EPS (37c), consensus (30c) GM General Motors $54.87 / -1.2 (-2.14%) 02/10/21 General Motors sees FY21 EBIT-adjusted of $1.5B-$2B 02/10/21 General Motors reports Q4 International EBIT-adjusted of $0.3B 02/10/21 General Motors sees FY21 adjusted EPS $4.50-$5.25, consensus $5.89 02/10/21 General Motors reports Q4 GM North America EBIT-adjusted of $2.6B FB Facebook $271.90 / +2.36 (+0.88%) 01/27/21 Facebook reports Q4 EPS $3.88, consensus $3.22 01/27/21 Notable companies reporting after market close 10/29/20 Facebook sees Q4 ad revenue growth rate higher than Q3 10/29/20 Facebook reports Q3 EPS $2.71, consensus $1.91 CSCO Cisco $47.25 / -1.19 (-2.46%) 02/09/21 Cisco sees Q3 adjusted EPS 80c-82c, consensus 81c 02/09/21 Cisco reports Q2 adjusted EPS 79c, consensus 76c 11/12/20 Cisco jumps 8% to $41.72 after Q1 results beat estimates AKAM Akamai $105.09 / -12.92 (-10.95%) 02/09/21 Akamai sees FY21 EPS $5.33-$5.46, consensus $5.46 02/09/21 Akamai sees Q1 EPS $1.28-$1.31, consensus $1.29 02/09/21 Akamai reports Q4 adjusted EPS $1.33, consensus $1.31 02/09/21 Notable companies reporting after market close 19 May YELP WMT TWTR TEVA ORCL MTCH LYFT KO GM FB CSCO YELP Yelp $36.82 / -1.74 (-4.51%) 12/26/20 Yelp stock deserves positive review, Barron's says 11/11/20 Yelp CEO 'very encouraged' by DOJ case against Google, Bloomberg says 11/02/20 Insiders say Yelp 'preying' on small businesses, BI reports WMT Walmart $144.13 / -1.68 (-1.15%) 02/10/21 TikTok still in talks with U.S. over potential asset sale, SCMP reports 02/10/21 Biden asks judge to put TikTok case on hold, Bloomberg says 02/10/21 TikTok sale to Oracle, Walmart shelved indefinitely amid review, WSJ reports 01/26/21 Walgreens Boots Alliance set to name Starbucks COO Roz Brewer as CEO, WSJ says TWTR Twitter $67.78 / +7.88 (+13.16%) 02/08/21 Twitter mulls charging for TweetDeck, unique content, Bloomberg reports 02/05/21 Senators propose bill to limit liability shield for social media, Reuters says 02/01/21 Twitter denies access to certain accounts in India amid 'legal demand,' TC says 01/31/21 Billionaire Cohen quits Twitter, cites threats in GameStop uproar, Reuters says TEVA Teva $11.92 / -0.9 (-7.02%) 02/10/21 CEO says Teva in discussions to co-produce COVID vaccine, Reuters reports 02/09/21 Teva wins new hearing on $235M GSK patent verdict, Bloomberg reports 11/13/20 Teva facing EU antitrust investigation over Copaxone sales, Bloomberg reports 10/21/20 Purdue Pharma to plead guilty in $8B-plus deal, AP reports ORCL Oracle $63.27 / -0.4 (-0.63%) 01/21/21 Oracle picks Don Johnson to run new cloud and AI department, BI reports MTCH Match Group $171.00 / +11.97 (+7.53%) 09/24/20 Spotify, Match, Epic join forces to challenge App Store practices, Reuters says 08/17/20 Facebook backs Fortnite in Apple app fee battle, NY Post says 08/11/20 Match Group developing interactive features for users, WSJ reports LYFT Lyft $56.15 / +2.56 (+4.78%) 01/12/21 Uber, Lyft drivers and union sue over Prop. 22, Axios reports 11/24/20 Uber, Lyft awarded five-year contract by GSA worth up to $810M, Reuters reports 11/23/20 Key Biden technology adviser makes regulation seem more likely, Reuters says 11/07/20 Gig-work companies win in CA, still facing battles elsewhere, Barron's says KO Coca-Cola $49.60 / -0.09 (-0.18%) 01/15/21 Coca-Cola won't run ads during Super Bowl, Variety reports 01/02/21 Coca-Cola, Disney among value stocks deserving a fresh look, Barron's says 12/19/20 Alphabet, Apple among Barron's 10 Top stocks for 2021, Barron's says 12/17/20 Coca-Cola reducing U.S. staff by 12%, cutting 2,200 jobs globally, WSJ reports GM General Motors $54.87 / -1.2 (-2.14%) 02/02/21 'Apple Car' to use E-GMP platform from Hyundai, Apple Insider reports 01/29/21 SoftBank CEO sees mass output of self-driving cars in two years, Reuters says 01/17/21 GM to invest $800M for EV output at Ontario plant, Bloomberg reports 01/14/21 GM planning expansion of Corvette line into SUVs, Bloomberg reports FB Facebook $271.90 / +2.36 (+0.88%) 02/10/21 Facebook working on product to compete with Clubhouse, NY Times reports 02/08/21 EU's Vestager tells Apple to treat apps equally in privacy update, Reuters says 02/03/21 Instagram working on 'TikTok-like feel' with Vertical Stories, Tech Crunch says CSCO Cisco $47.25 / -1.19 (-2.46%) 01/19/21 NeoPhotonics speculated as potential takeover target at Dealreporter 01/14/21 Cisco in new deal to acquire Acacia for $115 per share, CNBC reports 01/08/21 Cisco to get order to temporarily stop Acacia ending merger deal, Bloomberg says 01/08/21 Cisco sues Acacia to stop company from breaking merger pact, Bloomberg reports YELP WMT TWTR TEVA ORCL MTCH MAT KO GMDA GM FB CSCO AKAM YELP Yelp $36.82 / -1.74 (-4.51%) 01/11/21 Zillow, Walgreens upgrades among today's top calls on Wall Street WMT Walmart $144.13 / -1.68 (-1.15%) 02/02/21 Fly Intel: What to watch in Amazon earnings report TWTR Twitter $67.78 / +7.88 (+13.16%) 02/10/21 #SocialStocks: President Biden shelves TikTok case, pending further review 02/10/21 Twitter jumps after quarterly report as user base surpasses 192M TEVA Teva $11.92 / -0.9 (-7.02%) 11/19/20 Fly Intel: Wall Street's top stories for Thursday 11/19/20 Fly Intel: Wall Street's top stories at midday ORCL Oracle $63.27 / -0.4 (-0.63%) 12/18/20 Palantir downgrade at Credit Suisse among today's top calls on Wall Street MTCH Match Group $171.00 / +11.97 (+7.53%) 02/04/21 Best Buy upgrade, ViacomCBS downgrade among today's top calls on Wall Street MAT Mattel $18.49 / -0.34 (-1.81%) 10/23/20 Fly Intel: Wall Street's top stories for Friday KO Coca-Cola $49.60 / -0.09 (-0.18%) 02/09/21 Fly Intel: What to watch in Coca-Cola earnings report GMDA Gamida Cell $12.41 / +2.49 (+25.10%) 12/07/20 Fly Intel: Wall Street's top stories for Monday GM General Motors $54.87 / -1.2 (-2.14%) 02/09/21 Fly Intel: Wall Street's top stories for Tuesday FB Facebook $271.90 / +2.36 (+0.88%) 02/04/21 Fly Intel: What to watch in Snap earnings report 02/03/21 Fly Intel: Wall Street's top stories for Wednesday 02/03/21 #SocialStocks: Facebook and Apple continue to trade blows CSCO Cisco $47.25 / -1.19 (-2.46%) 02/09/21 Fly Intel: After-Hours Movers AKAM Akamai $105.09 / -12.92 (-10.95%) 02/10/21 Fly Intel: Wall Street's top stories for Wednesday 02/10/21 Fly Intel: Wall Street's top stories at midday 02/10/21 Lithia Motors, Canopy Growth downgrades among today's top calls on Wall Street 02/10/21 Fly Intel: Pre-market Movers 02/11/21 Retail & Luxury 02/11/21 Technology & Internet Virtual Conference 02/10/21 Teva - TEVA 02/10/21 Coca-Cola - KO 02/10/21 General Motors - GM 02/18/21 Walmart - WMT 02/26/21 Mattel - MAT 04/29/21 Twitter - TWTR 02/24/21 Mattel Inc. 02/25/21 Mattel 02/25/21 Akamai Technologies 02/25/21 Twitter, Inc. YELP WMT TWTR TEVA ORCL MTCH MAT LYFT KO GMDA GM FB CSCO AKAM YELP Yelp $36.82 / -1.74 (-4.51%) 12/22/20 Yelp put volume heavy and directionally bearish 12/21/20 Yelp put volume heavy and directionally bearish 12/11/20 Yelp put volume heavy and directionally bearish 11/19/20 Yelp call volume above normal and directionally bullish WMT Walmart $144.13 / -1.68 (-1.15%) 11/17/20 Unusually active option classes on open November 17th 09/02/20 Notable open interest changes for September 2nd 09/02/20 Wal-Mart call buyer realizes 124% same-day gains 09/01/20 Early notable gainers among liquid option names on September 1st TWTR Twitter $67.78 / +7.88 (+13.16%) 02/10/21 Early notable gainers among liquid option names on February 10th 02/10/21 Notable open interest changes for February 10th 02/09/21 Twitter options imply 20.7% move in share price post-earnings 01/29/21 Twitter call volume above normal and directionally bullish TEVA Teva $11.92 / -0.9 (-7.02%) 02/02/21 Teva call volume above normal and directionally bullish 01/19/21 Teva call volume above normal and directionally bullish 01/06/21 Notable open interest changes for January 6th 01/04/21 Teva call volume above normal and directionally bullish ORCL Oracle $63.27 / -0.4 (-0.63%) 01/22/21 Unusually active option classes on open January 22nd 12/10/20 Oracle options imply 6.5% move in share price post-earnings 09/21/20 Early notable gainers among liquid option names on September 21st 09/11/20 Early notable gainers among liquid option names on September 11th MTCH Match Group $171.00 / +11.97 (+7.53%) 02/02/21 Match Group options imply 12.4% move in share price post-earnings 11/17/20 Unusual put flow in option market yesterday 11/16/20 Match Group put seller looking for 11-day $300k fling MAT Mattel $18.49 / -0.34 (-1.81%) 10/23/20 Early notable gainers among liquid option names on October 23rd 10/22/20 Mattel options imply 12.0% move in share price post-earnings 10/21/20 Mattel put volume heavy and directionally bearish 09/29/20 Early notable gainers among liquid option names on September 29th LYFT Lyft $56.15 / +2.56 (+4.78%) 02/09/21 Lyft options imply 13.2% move in share price post-earnings 01/19/21 Lyft call volume above normal and directionally bullish 12/21/20 Lyft put volume heavy and directionally bearish 12/01/20 Lyft call volume above normal and directionally bullish KO Coca-Cola $49.60 / -0.09 (-0.18%) 11/10/20 Coca Cola call volume above normal and directionally bullish 10/30/20 Coca Cola put volume heavy and directionally bearish 10/22/20 Unusually active option classes on open October 22nd 09/02/20 Coca Cola call volume above normal and directionally bullish GMDA Gamida Cell $12.41 / +2.49 (+25.10%) 01/19/21 Nine new option listings and thirteen option delistings on January 19th GM General Motors $54.87 / -1.2 (-2.14%) 01/28/21 General Motors call volume above normal and directionally bullish 01/20/21 Notable open interest changes for January 20th 01/19/21 Early notable gainers among liquid option names on January 19th 01/13/21 Early notable gainers among liquid option names on January 13th FB Facebook $271.90 / +2.36 (+0.88%) 01/27/21 Facebook options imply 11.6% move in share price post-earnings 01/15/21 Facebook call volume above normal and directionally bullish 12/21/20 Facebook call buyer realizes 33% same-day gains 12/10/20 Unusually active option classes on open December 10th CSCO Cisco $47.25 / -1.19 (-2.46%) 02/08/21 Unusually active option classes on open February 8th 02/05/21 Unusually active option classes on open February 5th 02/04/21 Unusually active option classes on open February 4th 01/11/21 Cisco call volume above normal and directionally bullish AKAM Akamai $105.09 / -12.92 (-10.95%) 02/09/21 Akamai options imply 9.0% move in share price post-earnings 01/15/21 Early notable gainers among liquid option names on January 15th 10/26/20 Early notable gainers among liquid option names on October 26th
On The Fly	Fly Intel: Wall Street's top stories at midday » 12:14 02/10/21 02/10 12:14 02/10/21 12:14 KO Coca-Cola $49.93 / +0.24 (+0.48%) , GM General Motors $54.17 / -1.9 (-3.39%) , TWTR Twitter $64.53 / +4.63 (+7.73%) , TEVA Teva $11.88 / -0.945 (-7.37%) , MTCH Match Group $168.32 / +9.29 (+5.84%) , GMDA Gamida Cell $12.86 / +2.94 (+29.64%) , LYFT Lyft $56.87 / +3.28 (+6.12%) , YELP Yelp $35.66 / -2.9 (-7.52%) , AKAM Akamai $104.21 / -13.805 (-11.70%) , CSCO Cisco $46.38 / -2.06 (-4.25%) , MAT Mattel $18.24 / -0.59 (-3.13%) , WMT Walmart $144.30 / -1.51 (-1.04%) , ORCL Oracle $63.18 / -0.49 (-0.77%) The major averages have… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options YELP WMT TWTR TEVA ORCL MTCH MAT LYFT KO GMDA GM CSCO AKAM YELP Yelp $35.66 / -2.9 (-7.52%) 02/09/21 Yelp expects to return to sustainable revenue growth in 2021 01/12/21 Yelp to display user feedback on health, safety practices of businesses 12/27/20 Fly Intel: Top five weekend stock stories 12/04/20 D. E. Shaw & Co. reports 5% passive stake in Yelp WMT Walmart $144.30 / -1.51 (-1.04%) 02/10/21 White House says potential TikTok deal still being reviewed 02/10/21 Jim Cramer says WSJ report of shelved TikTok sale not accurate 02/08/21 TikTok, Universal Music Group announce expanded global alliance 02/02/21 Walmart and Sam's Club pharmacies to administer COVID vaccine in federal program TWTR Twitter $64.53 / +4.63 (+7.73%) 02/09/21 Twitter to reset growth benchmarks after pandemic ebbs 02/09/21 Twitter maintaining investment posture in 2021 02/09/21 Twitter up fractionally to $60.05 after Q4 results, Q1 guidance 02/09/21 Twitter sees FY21 capital expenditures of $900M-$950M TEVA Teva $11.88 / -0.945 (-7.37%) 02/10/21 Teva says 'optimistic' about opioid settlement, but 'not optimistic' on timeline 02/10/21 Teva targets 28% operating margin by end of 2023 02/10/21 Teva says 'very optimistic' about biosimilar pipeline 01/29/21 Teva's BroPair Spiromax gets positive recommendation from EMA's CHMP ORCL Oracle $63.18 / -0.49 (-0.77%) 01/14/21 Microsoft, Oracle, Salseforce, others form Vaccination Credential Initiative MTCH Match Group $168.32 / +9.29 (+5.84%) 02/09/21 Match Group to acquire Hyperconnect for $1.725B in cash and stock 02/09/21 Match Group to acquire Hyperconnect for $1.725B in cash and stock 12/07/20 Match Group, RAINN enter partnership for dating safety 11/04/20 Match Group says future remains 'challenging to predict' MAT Mattel $18.24 / -0.59 (-3.13%) 02/09/21 Mattel implementing new 'Optimizing for Growth' program 12/08/20 Mattel names Jonathan Anschell chief legal officer 12/03/20 Mattel enters licensing agreement with PGS Entertainment for toys based on show 10/23/20 Mattel CEO: Our strategy is clearly working LYFT Lyft $56.87 / +3.28 (+6.12%) 02/09/21 Lyft jumps 5% to $56.50 per share after Q4 results 02/09/21 Lyft reports Q4 active riders 12,552, down 45.2% 01/22/21 Lyft urges vaccination officials to allow access for mobility-challenged KO Coca-Cola $49.93 / +0.24 (+0.48%) 02/10/21 Coca-Cola believes tax court 'misinterpreted and misapplied' in conclusions 02/10/21 Coca-Cola sees FY21 adjusted EPS 'at or above 2019 levels' 02/10/21 Coca-Cola sees improvement in business as vaccinations become widely available 02/10/21 Coca-Cola: Resolution in IRS tax dispute 'likely to take some time' GMDA Gamida Cell $12.86 / +2.94 (+29.64%) 02/09/21 Gamida Cell says phase 3 results show faster hematopoietic recovery 01/11/21 Gamida Cell to present full data from Phase 3 study of omidubicel at TCT meeting 12/14/20 FDA asks Gamida Cell for more manufacturing-related data for pre-BLA 12/09/20 Gamida Cell provides achieves all three secondary endpoints of omidubicel study GM General Motors $54.17 / -1.9 (-3.39%) 02/10/21 GM has no plans to invest in bitcoin 02/10/21 General Motors not commenting on dividend until 'later in the year' 02/10/21 GM not planning to partner with rideshare players as EV portfolio rolls out 02/10/21 General Motors sees 2H21 stronger than 1H21 CSCO Cisco $46.38 / -2.06 (-4.25%) 02/09/21 Cisco falls over 3% to $47 per share after Q2 earnings, Q3 guidance 02/09/21 Cisco increases quarterly dividend 3% to 37c per share 02/09/21 Cisco seeing 'encouraging signs of strength' across business 02/09/21 Cisco reports Q2 product sales $8.57B, service sales $3.39B AKAM Akamai $104.21 / -13.805 (-11.70%) 02/09/21 Akamai drops 6% to $110.70 after Q4 results, FY guidance 02/09/21 Akamai says expects to see traffic continue to grow in 2021 02/09/21 Akamai CEO says strong Q4 performance 'capped off an excellent year' 02/09/21 Akamai announces organizational realignment KO GM TWTR TEVA MTCH GMDA LYFT YELP AKAM CSCO MAT WMT ORCL KO Coca-Cola $49.93 / +0.24 (+0.48%) 01/19/21 Bernstein Coca-Cola initiated with an Outperform at Bernstein 01/13/21 HSBC Coca-Cola price target lowered to $58 from $61 at HSBC 01/07/21 Fly Intel: Top five analyst downgrades 01/07/21 JPMorgan Coca-Cola downgraded to Neutral on tax risks at JPMorgan GM General Motors $54.17 / -1.9 (-3.39%) 02/09/21 Barclays General Motors price target raised to $64 from $56 at Barclays 02/01/21 Wedbush Nikola upgraded to Neutral from Underperform at Wedbush 01/29/21 Morgan Stanley General Motors price target raised to $80 from $57 at Morgan Stanley 01/29/21 Morgan Stanley Ford downgraded to Underweight on 'ICE liability' at Morgan Stanley TWTR Twitter $64.53 / +4.63 (+7.73%) 02/10/21 KeyBanc Twitter price target raised to $80 from $65 at KeyBanc 02/10/21 Oppenheimer Twitter price target raised to $70 from $58 at Oppenheimer 02/10/21 Wedbush Twitter price target raised to $56.50 from $47 at Wedbush 02/10/21 Truist Twitter price target raised to $64 from $43 at Truist TEVA Teva $11.88 / -0.945 (-7.37%) 01/26/21 Piper Sandler Amarin in 'strong position' against Health Net, says Piper Sandler 12/21/20 Gabelli Teva named 'Best Idea for 2021' at Gabelli 11/27/20 H.C. Wainwright Corcept Therapeutics price target raised to $32 from $22 at H.C. Wainwright 11/24/20 Oppenheimer Teva initiated with a Perform at Oppenheimer MTCH Match Group $168.32 / +9.29 (+5.84%) 02/10/21 Wedbush Match Group price target raised to $150 from $135 at Wedbush 02/05/21 Citi Match Group price target raised to $175 from $160 at Citi 02/04/21 Fly Intel: Top five analyst upgrades 02/04/21 Match Group upgraded to Overweight on earnings pullback at JPMorgan GMDA Gamida Cell $12.86 / +2.94 (+29.64%) 02/10/21 H.C. Wainwright Gamida Cell price target raised to $27 from $15 at H.C. Wainwright 02/09/21 Piper Sandler Gamida Cell price target raised to $25 from $13 at Piper Sandler 12/14/20 Oppenheimer Gamida Cell price target lowered to $17 from $20 at Oppenheimer 12/14/20 Piper Sandler Gamida Cell delay does not impact peak sales, says Piper Sandler LYFT Lyft $56.87 / +3.28 (+6.12%) 02/10/21 DA Davidson Lyft price target raised to $66 from $58 at DA Davidson 02/10/21 Jefferies Lyft price target raised to $75 from $70 at Jefferies 02/10/21 KeyBanc Lyft price target raised to $72 from $57 at KeyBanc 02/10/21 Credit Suisse Lyft price target raised to $74 from $66 at Credit Suisse YELP Yelp $35.66 / -2.9 (-7.52%) 02/10/21 Truist Yelp price target raised to $40 from $30 at Truist 02/10/21 Credit Suisse Yelp price target raised to $41 from $35 at Credit Suisse 02/10/21 Wedbush Yelp price target raised to $38 from $30 at Wedbush 02/10/21 UBS Yelp price target raised to $40 from $30 at UBS AKAM Akamai $104.21 / -13.805 (-11.70%) 02/10/21 Fly Intel: Top five analyst downgrades 02/10/21 Craig-Hallum Akamai downgraded to Hold at Craig-Hallum 02/10/21 Credit Suisse Akamai price target raised to $115 from $105 at Credit Suisse 02/10/21 Craig-Hallum Akamai downgraded to Hold from Buy at Craig-Hallum CSCO Cisco $46.38 / -2.06 (-4.25%) 02/10/21 Evercore ISI Cisco trends 'slowly but steadily inflecting higher,' says Evercore ISI 02/10/21 Citi Cisco price target raised to $50 from $45 at Citi 02/10/21 Piper Sandler Cisco price target raised to $47 from $45 at Piper Sandler 01/25/21 JPMorgan Cisco price target raised to $50 from $44 at JPMorgan MAT Mattel $18.24 / -0.59 (-3.13%) 02/10/21 KeyBanc Mattel price target raised to $22 from $17 at KeyBanc 12/09/20 Citi Mattel initiated with a Neutral at Citi 11/09/20 Fly Intel: Top five analyst downgrades 11/09/20 Jefferies Jefferies downgrades Mattel to Hold as stock nears $15 price target WMT Walmart $144.30 / -1.51 (-1.04%) 02/09/21 Jefferies Dollar General well-positioned to mitigate minimum wage headwind, says Jefferies 01/29/21 Jefferies Carvana, Walmart among 13 additions to Jefferies Franchise Picks list 01/25/21 Fly Intel: Top five analyst downgrades 01/25/21 R5 Capital R5 Capital downgrades 'operationally challenged' Walmart to Sell ORCL Oracle $63.18 / -0.49 (-0.77%) 01/21/21 Goldman Sachs Oracle initiated with a Sell at Goldman Sachs 12/18/20 Fly Intel: Top five analyst upgrades 12/18/20 Monness Crespi Monness Crespi upgrades 'value play' Oracle to Buy with $82 price target 12/18/20 Monness Crespi Oracle upgraded to Buy from Neutral at Monness Crespi YELP WMT TWTR TEVA ORCL MTCH MAT LYFT KO GMDA GM CSCO AKAM YELP Yelp $35.66 / -2.9 (-7.52%) 02/09/21 Yelp sees FY21 net revenue $985M-$1.005B, consensus $979.22M 02/09/21 Yelp reports Q4 EPS 27c, consensus 27c 11/05/20 Yelp sees Q4 revenue $220M-$230M, consensus $226.22M WMT Walmart $144.30 / -1.51 (-1.04%) 11/17/20 Walmart reports Q3 adjusted EPS $1.34, consensus $1.18 11/16/20 Notable companies reporting before tomorrow's open 08/18/20 Walmart reports Q2 adjusted EPS $1.56, consensus $1.25 TWTR Twitter $64.53 / +4.63 (+7.73%) 02/09/21 Twitter sees Q1 revenue $940M-$1.04B, consensus $965.14M 02/09/21 Twitter reports Q4 adjusted EPS 38c, consensus 31c 02/09/21 Notable companies reporting after market close 10/29/20 Twitter reports Q3 adjusted EPS 19c, consensus 6c TEVA Teva $11.88 / -0.945 (-7.37%) 02/10/21 Teva sees Q1 lowest for EPS, sales in FY21 02/10/21 Teva sees FY21 EBITDA $4.8B-$5.1B 02/10/21 Teva sees FY21 EPS $2.50-$2.70, consensus $2.63 02/10/21 Teva reports Q4 EPS 68c, consensus 63c ORCL Oracle $63.18 / -0.49 (-0.77%) 12/10/20 Oracle sees Q3 revenue up 1%-3% in constant FX, up 2%-4% in USD 12/10/20 Oracle sees Q3 EPS up 10%-14% to $1.06-$1.10 at constant FX, consensus $1.04 12/10/20 Oracle reports Q2 adjusted EPS $1.06, consensus $1.00 12/10/20 Notable companies reporting after market close MTCH Match Group $168.32 / +9.29 (+5.84%) 02/02/21 Match Group sees Q1 revenue of $645M-$655M, consensus $646.6M 02/02/21 Match Group sees FY21 revenue $2.75B-$2.85B, consensus $2.84B 02/02/21 Match Group reports Q4 EPS 48c, consensus 49c 02/02/21 Notable companies reporting after market close MAT Mattel $18.24 / -0.59 (-3.13%) 02/09/21 Mattel sees FY21 adjusted EBITDA $775M-$800M vs. $719M last year 02/09/21 Mattel reports Q4 adjusted EPS 40c, consensus 23c 10/22/20 Mattel sees 'strong' adjusted EBITDA growth for FY20 vs. FY19 LYFT Lyft $56.87 / +3.28 (+6.12%) 02/09/21 Lyft reports Q4 revenue $569.9M, consensus $562.49M 12/02/20 Lyft sees Q4 sequential revenue growth at lower end of 11%-15% range 11/10/20 Lyft reports Q3 adj. EPS (89c), consensus (91c) KO Coca-Cola $49.93 / +0.24 (+0.48%) 02/10/21 Coca-Cola says Q1 adjusted EPS to include an approximate 2% currency headwind 02/10/21 Coca-Cola sees FY21 adjusted EPS growth high single digits to low double digits 02/10/21 Coca-Cola reports Q4 adjusted EPS 47c, consensus 42c 02/09/21 Notable companies reporting before tomorrow's open GMDA Gamida Cell $12.86 / +2.94 (+29.64%) 11/10/20 Gamida Cell reports Q3 EPS (30c), consensus (31c) 08/11/20 Gamida Cell reports Q2 EPS (37c), consensus (30c) GM General Motors $54.17 / -1.9 (-3.39%) 02/10/21 General Motors sees FY21 EBIT-adjusted of $1.5B-$2B 02/10/21 General Motors reports Q4 International EBIT-adjusted of $0.3B 02/10/21 General Motors sees FY21 adjusted EPS $4.50-$5.25, consensus $5.89 02/10/21 General Motors reports Q4 GM North America EBIT-adjusted of $2.6B CSCO Cisco $46.38 / -2.06 (-4.25%) 02/09/21 Cisco sees Q3 adjusted EPS 80c-82c, consensus 81c 02/09/21 Cisco reports Q2 adjusted EPS 79c, consensus 76c 11/12/20 Cisco jumps 8% to $41.72 after Q1 results beat estimates AKAM Akamai $104.21 / -13.805 (-11.70%) 02/09/21 Akamai sees FY21 EPS $5.33-$5.46, consensus $5.46 02/09/21 Akamai sees Q1 EPS $1.28-$1.31, consensus $1.29 02/09/21 Akamai reports Q4 adjusted EPS $1.33, consensus $1.31 19 May YELP WMT TWTR TEVA ORCL MTCH LYFT KO GM CSCO YELP Yelp $35.66 / -2.9 (-7.52%) 12/26/20 Yelp stock deserves positive review, Barron's says 11/11/20 Yelp CEO 'very encouraged' by DOJ case against Google, Bloomberg says 11/02/20 Insiders say Yelp 'preying' on small businesses, BI reports WMT Walmart $144.30 / -1.51 (-1.04%) 02/10/21 TikTok sale to Oracle, Walmart shelved indefinitely amid review, WSJ reports 01/26/21 Walgreens Boots Alliance set to name Starbucks COO Roz Brewer as CEO, WSJ says 01/22/21 Walmart to expand vaccination program, Reuters reports 01/20/21 Watchdog challenges Walmart's 'Made in USA' claims, NY Post reports TWTR Twitter $64.53 / +4.63 (+7.73%) 02/08/21 Twitter mulls charging for TweetDeck, unique content, Bloomberg reports 02/05/21 Senators propose bill to limit liability shield for social media, Reuters says 02/01/21 Twitter denies access to certain accounts in India amid 'legal demand,' TC says 01/31/21 Billionaire Cohen quits Twitter, cites threats in GameStop uproar, Reuters says TEVA Teva $11.88 / -0.945 (-7.37%) 02/10/21 CEO says Teva in discussions to co-produce COVID vaccine, Reuters reports 02/09/21 Teva wins new hearing on $235M GSK patent verdict, Bloomberg reports 11/13/20 Teva facing EU antitrust investigation over Copaxone sales, Bloomberg reports 10/21/20 Purdue Pharma to plead guilty in $8B-plus deal, AP reports ORCL Oracle $63.18 / -0.49 (-0.77%) 01/21/21 Oracle picks Don Johnson to run new cloud and AI department, BI reports 12/14/20 Oracle's Ellison latest billionaire to leave California, Recode says 11/25/20 Bytedance receives extension for TikTok divestiture order, Reuters reports MTCH Match Group $168.32 / +9.29 (+5.84%) 09/24/20 Spotify, Match, Epic join forces to challenge App Store practices, Reuters says 08/17/20 Facebook backs Fortnite in Apple app fee battle, NY Post says 08/11/20 Match Group developing interactive features for users, WSJ reports LYFT Lyft $56.87 / +3.28 (+6.12%) 01/12/21 Uber, Lyft drivers and union sue over Prop. 22, Axios reports 11/24/20 Uber, Lyft awarded five-year contract by GSA worth up to $810M, Reuters reports 11/23/20 Key Biden technology adviser makes regulation seem more likely, Reuters says 11/07/20 Gig-work companies win in CA, still facing battles elsewhere, Barron's says KO Coca-Cola $49.93 / +0.24 (+0.48%) 01/15/21 Coca-Cola won't run ads during Super Bowl, Variety reports 01/02/21 Coca-Cola, Disney among value stocks deserving a fresh look, Barron's says 12/19/20 Alphabet, Apple among Barron's 10 Top stocks for 2021, Barron's says 12/17/20 Coca-Cola reducing U.S. staff by 12%, cutting 2,200 jobs globally, WSJ reports GM General Motors $54.17 / -1.9 (-3.39%) 02/02/21 'Apple Car' to use E-GMP platform from Hyundai, Apple Insider reports 01/29/21 SoftBank CEO sees mass output of self-driving cars in two years, Reuters says 01/17/21 GM to invest $800M for EV output at Ontario plant, Bloomberg reports 01/14/21 GM planning expansion of Corvette line into SUVs, Bloomberg reports CSCO Cisco $46.38 / -2.06 (-4.25%) 01/19/21 NeoPhotonics speculated as potential takeover target at Dealreporter 01/14/21 Cisco in new deal to acquire Acacia for $115 per share, CNBC reports 01/08/21 Cisco to get order to temporarily stop Acacia ending merger deal, Bloomberg says 01/08/21 Cisco sues Acacia to stop company from breaking merger pact, Bloomberg reports YELP WMT TWTR TEVA ORCL MTCH MAT LYFT KO GMDA GM CSCO AKAM YELP Yelp $35.66 / -2.9 (-7.52%) 01/11/21 Zillow, Walgreens upgrades among today's top calls on Wall Street 11/09/20 Biogen downgrade, Fisker initiation among today's top calls on Wall Street 11/06/20 Fly Intel: Wall Street's top stories for Friday WMT Walmart $144.30 / -1.51 (-1.04%) 02/02/21 Fly Intel: What to watch in Amazon earnings report 01/25/21 Walmart downgrade, Alibaba initiation among today's top calls on Wall Street 01/22/21 Fly Intel: Wall Street's top stories for Friday 01/22/21 Fly Intel: Wall Street's top stories at midday TWTR Twitter $64.53 / +4.63 (+7.73%) 02/10/21 Twitter jumps after quarterly report as user base surpasses 192M 02/09/21 Fly Intel: After-Hours Movers 02/09/21 Fly Intel: What to watch in Twitter earnings report 02/04/21 Fly Intel: What to watch in Snap earnings report TEVA Teva $11.88 / -0.945 (-7.37%) 11/19/20 Fly Intel: Wall Street's top stories for Thursday 11/19/20 Fly Intel: Wall Street's top stories at midday 11/18/20 Fly Intel: After-Hours Movers 08/26/20 Fly Intel: Pre-market Movers ORCL Oracle $63.18 / -0.49 (-0.77%) 12/18/20 Palantir downgrade at Credit Suisse among today's top calls on Wall Street 12/16/20 Microsoft reinstatement, Spotify downgrade among top calls on Wall Street 12/11/20 Fly Intel: Wall Street's top stories for Friday 12/11/20 Fly Intel: Wall Street's top stories at midday MTCH Match Group $168.32 / +9.29 (+5.84%) 02/04/21 Best Buy upgrade, ViacomCBS downgrade among today's top calls on Wall Street 02/02/21 Fly Intel: After-Hours Movers 11/04/20 Fly Intel: After-Hours Movers MAT Mattel $18.24 / -0.59 (-3.13%) 10/23/20 Fly Intel: Wall Street's top stories for Friday 10/23/20 Fly Intel: Wall Street's top stories at midday 10/23/20 Fly Intel: Pre-market Movers LYFT Lyft $56.87 / +3.28 (+6.12%) 02/09/21 Fly Intel: What to watch in Uber, Lyft earnings reports KO Coca-Cola $49.93 / +0.24 (+0.48%) 02/10/21 Fly Intel: Pre-market Movers 02/09/21 Fly Intel: What to watch in Coca-Cola earnings report 01/07/21 Tesla upgrade, Coca-Cola downgrade among today's top calls on Wall Street 01/06/21 Coca-Cola, PepsiCo downgrades among today's top calls on Wall Street GMDA Gamida Cell $12.86 / +2.94 (+29.64%) 12/07/20 Fly Intel: Wall Street's top stories for Monday 12/07/20 Crispr rises following ASH update for genome editing cell therapy candidate 12/07/20 Fly Intel: Wall Street's top stories at midday GM General Motors $54.17 / -1.9 (-3.39%) 02/09/21 Fly Intel: Wall Street's top stories for Tuesday 02/09/21 Fly Intel: Wall Street's top stories at midday 02/06/21 Charged: Apple, Hyundai-Kia said to be close to 'Apple Car' deal CSCO Cisco $46.38 / -2.06 (-4.25%) 01/14/21 Fly Intel: Wall Street's top stories for Thursday 01/14/21 Fly Intel: Wall Street's top stories at midday AKAM Akamai $104.21 / -13.805 (-11.70%) 02/10/21 Lithia Motors, Canopy Growth downgrades among today's top calls on Wall Street 12/08/20 Fastly jumps after report of DNS work with Apple 02/11/21 Technology & Internet Virtual Conference 02/10/21 Teva - TEVA 02/10/21 Coca-Cola - KO 02/10/21 General Motors - GM 02/18/21 Walmart - WMT 02/26/21 Mattel - MAT 04/29/21 Twitter - TWTR 02/24/21 Mattel Inc. 02/25/21 Mattel 02/25/21 Akamai Technologies 02/25/21 Twitter, Inc. YELP WMT TWTR TEVA ORCL MTCH MAT LYFT KO GMDA GM CSCO AKAM YELP Yelp $35.66 / -2.9 (-7.52%) 12/22/20 Yelp put volume heavy and directionally bearish 12/21/20 Yelp put volume heavy and directionally bearish 12/11/20 Yelp put volume heavy and directionally bearish 11/19/20 Yelp call volume above normal and directionally bullish WMT Walmart $144.30 / -1.51 (-1.04%) 11/17/20 Unusually active option classes on open November 17th 09/02/20 Notable open interest changes for September 2nd 09/02/20 Wal-Mart call buyer realizes 124% same-day gains 09/01/20 Early notable gainers among liquid option names on September 1st TWTR Twitter $64.53 / +4.63 (+7.73%) 02/10/21 Early notable gainers among liquid option names on February 10th 02/10/21 Notable open interest changes for February 10th 02/09/21 Twitter options imply 20.7% move in share price post-earnings 01/29/21 Twitter call volume above normal and directionally bullish TEVA Teva $11.88 / -0.945 (-7.37%) 02/02/21 Teva call volume above normal and directionally bullish 01/19/21 Teva call volume above normal and directionally bullish 01/06/21 Notable open interest changes for January 6th 01/04/21 Teva call volume above normal and directionally bullish ORCL Oracle $63.18 / -0.49 (-0.77%) 01/22/21 Unusually active option classes on open January 22nd 12/10/20 Oracle options imply 6.5% move in share price post-earnings 09/21/20 Early notable gainers among liquid option names on September 21st 09/11/20 Early notable gainers among liquid option names on September 11th MTCH Match Group $168.32 / +9.29 (+5.84%) 02/02/21 Match Group options imply 12.4% move in share price post-earnings 11/17/20 Unusual put flow in option market yesterday 11/16/20 Match Group put seller looking for 11-day $300k fling MAT Mattel $18.24 / -0.59 (-3.13%) 10/23/20 Early notable gainers among liquid option names on October 23rd 10/22/20 Mattel options imply 12.0% move in share price post-earnings 10/21/20 Mattel put volume heavy and directionally bearish 09/29/20 Early notable gainers among liquid option names on September 29th LYFT Lyft $56.87 / +3.28 (+6.12%) 02/09/21 Lyft options imply 13.2% move in share price post-earnings 01/19/21 Lyft call volume above normal and directionally bullish 12/21/20 Lyft put volume heavy and directionally bearish 12/01/20 Lyft call volume above normal and directionally bullish KO Coca-Cola $49.93 / +0.24 (+0.48%) 11/10/20 Coca Cola call volume above normal and directionally bullish 10/30/20 Coca Cola put volume heavy and directionally bearish 10/22/20 Unusually active option classes on open October 22nd 09/02/20 Coca Cola call volume above normal and directionally bullish GMDA Gamida Cell $12.86 / +2.94 (+29.64%) 01/19/21 Nine new option listings and thirteen option delistings on January 19th GM General Motors $54.17 / -1.9 (-3.39%) 01/28/21 General Motors call volume above normal and directionally bullish 01/20/21 Notable open interest changes for January 20th 01/19/21 Early notable gainers among liquid option names on January 19th 01/13/21 Early notable gainers among liquid option names on January 13th CSCO Cisco $46.38 / -2.06 (-4.25%) 02/08/21 Unusually active option classes on open February 8th 02/05/21 Unusually active option classes on open February 5th 02/04/21 Unusually active option classes on open February 4th 01/11/21 Cisco call volume above normal and directionally bullish AKAM Akamai $104.21 / -13.805 (-11.70%) 02/09/21 Akamai options imply 9.0% move in share price post-earnings 01/15/21 Early notable gainers among liquid option names on January 15th 10/26/20 Early notable gainers among liquid option names on October 26th
On The Fly	Fly Intel: Pre-market Movers » 08:57 02/10/21 02/10 08:57 02/10/21 08:57 GMDA Gamida Cell $9.92 / -0.19 (-1.88%) , ACIC Atlas Crest Investment Corp. $11.15 / -0.1 (-0.89%) , CMLF CM Life Sciences $15.50 / +1.325 (+9.35%) , KO Coca-Cola $49.70 / -0.23 (-0.46%) , GM General Motors $56.07 / -0.82 (-1.44%) , IQV Iqvia $184.05 / -2.81 (-1.50%) , LYFT Lyft $53.59 / +0.16 (+0.30%) , CSCO Cisco $48.44 / -0.49 (-1.00%) , AKAM Akamai $118.01 / +0.73 (+0.62%) , SAVA Cassava Sciences $57.40 / -3.16 (-5.22%) , ENLV Enlivex Therapeutics $23.90 / +0.85 (+3.69%) , XONE ExOne $64.40 / +9.9 (+18.17%) , ACHR Archer $0.00 / + (+0.00%) , UAL United Airlines $43.32 / -1.03 (-2.32%) Check out this morning's… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options XONE UAL SAVA LYFT KO IQV GMDA GM ENLV CSCO CMLF AKAM ACIC XONE ExOne $64.40 / +9.9 (+18.17%) 02/08/21 ExOne jumps 34% after partnership, preliminary quarterly results 02/08/21 ExOne launches the ExOne Metal Designlab printer in partnership with Rapidia 01/26/21 ExOne to 3D print lightweight ceramic-metal parts 10/22/20 ExOne awarded contract from NCDMM UAL United Airlines $43.32 / -1.03 (-2.32%) 02/10/21 Mesa Air partners with United Airlines, Archer to combat climate change 01/31/21 Fly Intel: Top five weekend stock stories 01/27/21 United Airlines expands COVID-19 testing, pre-clearance for Hawaii travel SAVA Cassava Sciences $57.40 / -3.16 (-5.22%) 02/08/21 Cassava Sciences expects FY21 net cash use $20M-$25M 02/08/21 Cassava Sciences announces expected 2021 key milestones 02/02/21 Cassava Sciences trading resumes 02/02/21 Cassava Sciences' simufilam shows improved cognition and behavior in Alzheimer's LYFT Lyft $53.59 / +0.16 (+0.30%) 02/09/21 Lyft jumps 5% to $56.50 per share after Q4 results 02/09/21 Lyft reports Q4 active riders 12,552, down 45.2% 01/22/21 Lyft urges vaccination officials to allow access for mobility-challenged 01/14/21 First Transit in to agreement with Lyft for operations of Biketown KO Coca-Cola $49.70 / -0.23 (-0.46%) 02/10/21 Coca-Cola sees improvement in business as vaccinations become widely available 02/10/21 Coca-Cola: Resolution in IRS tax dispute 'likely to take some time' 02/10/21 Coca-Cola believes it will ultimately prevail on appeal in IRS tax dispute 02/10/21 Coca-Cola says Q4 value share in total NARTD beverages was even IQV Iqvia $184.05 / -2.81 (-1.50%) 12/21/20 Q2 Solutions teams with Adaptive Biotechnologies to market immunoSEQ Assay 12/16/20 Iqvia in pact with Servier to 'reinvent' its R&D clinical development processes 11/18/20 Iqvia's Rittenmeyer sells over 40,000 common shares 11/13/20 Third Point takes stake in PG&E, boosts Alibaba stake, exits Baxter GMDA Gamida Cell $9.92 / -0.19 (-1.88%) 02/09/21 Gamida Cell says phase 3 results show faster hematopoietic recovery 01/11/21 Gamida Cell to present full data from Phase 3 study of omidubicel at TCT meeting 12/14/20 FDA asks Gamida Cell for more manufacturing-related data for pre-BLA 12/09/20 Gamida Cell provides achieves all three secondary endpoints of omidubicel study GM General Motors $56.07 / -0.82 (-1.44%) 02/10/21 General Motors sees FY21 CapEx $9B-$10B 02/09/21 General Motors extending downtime at plants due to semiconductor supply 02/03/21 GM reports chip shortage, will affect production in 2021 01/28/21 General Motors to offer 30 all-electric models globally by mid-decade ENLV Enlivex Therapeutics $23.90 / +0.85 (+3.69%) 02/08/21 Enlivex Therapeutics trading resumes 02/08/21 Enlivex Therapeutics trading halted, volatility trading pause 02/03/21 Enlivex Therapeutics reports topline results from Phase II trial of Allocetra 12/21/20 Enlivex announces publication of results for Phase Ib severe sepsis trial CSCO Cisco $48.44 / -0.49 (-1.00%) 02/09/21 Cisco falls over 3% to $47 per share after Q2 earnings, Q3 guidance 02/09/21 Cisco increases quarterly dividend 3% to 37c per share 02/09/21 Cisco seeing 'encouraging signs of strength' across business 02/09/21 Cisco reports Q2 product sales $8.57B, service sales $3.39B CMLF CM Life Sciences $15.50 / +1.325 (+9.35%) 02/10/21 CM Life Sciences Inc (Class A Stock) trading resumes 02/10/21 Clinical data platform Sema4 to combine with SPAC CM Life Sciences AKAM Akamai $118.01 / +0.73 (+0.62%) 02/09/21 Akamai drops 6% to $110.70 after Q4 results, FY guidance 02/09/21 Akamai says expects to see traffic continue to grow in 2021 02/09/21 Akamai CEO says strong Q4 performance 'capped off an excellent year' 02/09/21 Akamai announces organizational realignment ACIC Atlas Crest Investment Corp. $11.15 / -0.1 (-0.89%) 02/10/21 Urban air mobility company Archer to list on NYSE via Atlas Crest merger GMDA ACIC CMLF KO GM IQV LYFT CSCO AKAM SAVA ENLV XONE ACHR UAL GMDA Gamida Cell $9.92 / -0.19 (-1.88%) 02/10/21 H.C. Wainwright Gamida Cell price target raised to $27 from $15 at H.C. Wainwright 02/09/21 Piper Sandler Gamida Cell price target raised to $25 from $13 at Piper Sandler 12/14/20 Oppenheimer Gamida Cell price target lowered to $17 from $20 at Oppenheimer 12/14/20 Piper Sandler Gamida Cell delay does not impact peak sales, says Piper Sandler ACIC Atlas Crest Investment Corp. $11.15 / -0.1 (-0.89%) CMLF CM Life Sciences $15.50 / +1.325 (+9.35%) KO Coca-Cola $49.70 / -0.23 (-0.46%) 01/19/21 Bernstein Coca-Cola initiated with an Outperform at Bernstein 01/13/21 HSBC Coca-Cola price target lowered to $58 from $61 at HSBC 01/07/21 Fly Intel: Top five analyst downgrades 01/07/21 JPMorgan Coca-Cola downgraded to Neutral on tax risks at JPMorgan GM General Motors $56.07 / -0.82 (-1.44%) 02/09/21 Barclays General Motors price target raised to $64 from $56 at Barclays 02/01/21 Wedbush Nikola upgraded to Neutral from Underperform at Wedbush 01/29/21 Morgan Stanley General Motors price target raised to $80 from $57 at Morgan Stanley 01/29/21 Morgan Stanley Ford downgraded to Underweight on 'ICE liability' at Morgan Stanley IQV Iqvia $184.05 / -2.81 (-1.50%) 12/18/20 Mizuho Iqvia price target raised to $200 from $190 at Mizuho 10/22/20 Deutsche Bank Iqvia price target raised to $196 from $180 at Deutsche Bank 10/21/20 UBS Iqvia price target raised to $224 from $204 at UBS 10/21/20 Morgan Stanley Iqvia price target raised to $195 from $182 at Morgan Stanley LYFT Lyft $53.59 / +0.16 (+0.30%) 02/10/21 Credit Suisse Lyft price target raised to $74 from $66 at Credit Suisse 02/10/21 MKM Partners Lyft price target raised to $58 from $37 at MKM Partners 02/10/21 Wedbush Lyft price target raised to $72 from $53 at Wedbush 02/10/21 Morgan Stanley Lyft price target raised to $60 from $55 at Morgan Stanley CSCO Cisco $48.44 / -0.49 (-1.00%) 02/10/21 Evercore ISI Cisco trends 'slowly but steadily inflecting higher,' says Evercore ISI 02/10/21 Citi Cisco price target raised to $50 from $45 at Citi 02/10/21 Piper Sandler Cisco price target raised to $47 from $45 at Piper Sandler 01/25/21 JPMorgan Cisco price target raised to $50 from $44 at JPMorgan AKAM Akamai $118.01 / +0.73 (+0.62%) 02/10/21 Credit Suisse Akamai price target raised to $115 from $105 at Credit Suisse 02/10/21 Craig-Hallum Akamai downgraded to Hold from Buy at Craig-Hallum 02/10/21 JPMorgan Akamai downgraded to Neutral from Overweight at JPMorgan 11/12/20 Piper Sandler Akamai price target lowered to $120 from $125 at Piper Sandler SAVA Cassava Sciences $57.40 / -3.16 (-5.22%) 02/02/21 Cantor Fitzgerald Cantor says Cassava analyses 'encouraging,' but should be viewed with caution 10/22/20 Cantor Fitzgerald Cassava Sciences initiated with an Overweight at Cantor Fitzgerald 09/23/20 H.C. Wainwright Cassava Sciences upgraded to Buy from Neutral at H.C. Wainwright 09/14/20 Maxim Cassava upgraded to Buy at Maxim after second analysis of AD drug data ENLV Enlivex Therapeutics $23.90 / +0.85 (+3.69%) 03/10/20 H.C. Wainwright Enlivex Therapeutics price target raised to $22 from $20 at H.C. Wainwright XONE ExOne $64.40 / +9.9 (+18.17%) 02/09/21 B. Riley ExOne price target raised to $44 from $10.50 at B. Riley Securities 02/08/21 Canaccord ExOne price target raised to $59 from $18 at Canaccord 01/29/21 Alliance Global Partners ExOne upgraded to Buy from Neutral at Alliance Global Partners 01/19/21 Stifel ExOne initiated with a Buy at Stifel ACHR Archer $0.00 / + (+0.00%) UAL United Airlines $43.32 / -1.03 (-2.32%) 02/10/21 JPMorgan JPMorgan sees less than 15% chance of pre-flight COVID-19 testing 01/14/21 Susquehanna United Airlines price target raised to $40 from $38 at Susquehanna 01/11/21 Cowen United Airlines upgraded to Outperform from Market Perform at Cowen 01/08/21 Fly Intel: Top five analyst downgrades XONE UAL SAVA LYFT KO IQV GMDA GM CSCO AKAM XONE ExOne $64.40 / +9.9 (+18.17%) 11/05/20 ExOne reports Q3 EPS (19c), consensus (20c) UAL United Airlines $43.32 / -1.03 (-2.32%) 01/20/21 United Airlines ended 2020 with $19.7B in available liquidity 01/20/21 United sees Q1 operating revenue down 65%-70%, consensus $4.06B 01/20/21 United Airlines reports Q4 adjusted EPS ($7.00), consensus ($6.60) 01/20/21 Notable companies reporting after market close SAVA Cassava Sciences $57.40 / -3.16 (-5.22%) 11/09/20 Cassava Sciences reports Q3 EPS (6c), consensus (7c) 08/12/20 Cassava Sciences reports Q2 EPS (5c) vs. (6c) last year LYFT Lyft $53.59 / +0.16 (+0.30%) 02/09/21 Lyft reports Q4 revenue $569.9M, consensus $562.49M 02/09/21 Notable companies reporting after market close 12/02/20 Lyft sees Q4 sequential revenue growth at lower end of 11%-15% range 11/10/20 Lyft reports Q3 adj. EPS (89c), consensus (91c) KO Coca-Cola $49.70 / -0.23 (-0.46%) 02/10/21 Coca-Cola says Q1 adjusted EPS to include an approximate 2% currency headwind 02/10/21 Coca-Cola sees FY21 adjusted EPS growth high single digits to low double digits 02/10/21 Coca-Cola reports Q4 adjusted EPS 47c, consensus 42c 02/09/21 Notable companies reporting before tomorrow's open IQV Iqvia $184.05 / -2.81 (-1.50%) 02/10/21 Iqvia raises FY21 adjusted EPS view to $7.77-$8.08 from $7.65-$7.95 02/10/21 Iqvia sees Q1 adjusted EPS $1.81-$1.87, consensus $1.80 02/10/21 Iqvia reports Q4 adjusted EPS $2.11, consensus $2.00 GMDA Gamida Cell $9.92 / -0.19 (-1.88%) 11/10/20 Gamida Cell reports Q3 EPS (30c), consensus (31c) 08/11/20 Gamida Cell reports Q2 EPS (37c), consensus (30c) GM General Motors $56.07 / -0.82 (-1.44%) 02/10/21 General Motors sees FY21 EBIT-adjusted of $1.5B-$2B 02/10/21 General Motors reports Q4 International EBIT-adjusted of $0.3B 02/10/21 General Motors sees FY21 adjusted EPS $4.50-$5.25, consensus $5.89 02/10/21 General Motors reports Q4 GM North America EBIT-adjusted of $2.6B CSCO Cisco $48.44 / -0.49 (-1.00%) 02/09/21 Cisco sees Q3 adjusted EPS 80c-82c, consensus 81c 02/09/21 Cisco reports Q2 adjusted EPS 79c, consensus 76c 11/12/20 Cisco jumps 8% to $41.72 after Q1 results beat estimates AKAM Akamai $118.01 / +0.73 (+0.62%) 02/09/21 Akamai sees FY21 EPS $5.33-$5.46, consensus $5.46 02/09/21 Akamai sees Q1 EPS $1.28-$1.31, consensus $1.29 02/09/21 Akamai reports Q4 adjusted EPS $1.33, consensus $1.31 10 Feb 10 Feb 13 Nov 19 May 22 Apr UAL LYFT KO GM CSCO UAL United Airlines $43.32 / -1.03 (-2.32%) 01/31/21 CDC orders sweeping transportation mask mandate, Reuters reports 01/29/21 United warns staff their jobs are at risk when federal relief expires, CNBC says 01/24/21 Biden to impose South Africa travel ban to combat COVID variant, Reuters says 01/22/21 United Airlines CEO wants to require staff get vaccinated for COVID, CNBC says LYFT Lyft $53.59 / +0.16 (+0.30%) 01/12/21 Uber, Lyft drivers and union sue over Prop. 22, Axios reports 11/24/20 Uber, Lyft awarded five-year contract by GSA worth up to $810M, Reuters reports 11/23/20 Key Biden technology adviser makes regulation seem more likely, Reuters says 11/07/20 Gig-work companies win in CA, still facing battles elsewhere, Barron's says KO Coca-Cola $49.70 / -0.23 (-0.46%) 01/15/21 Coca-Cola won't run ads during Super Bowl, Variety reports 01/02/21 Coca-Cola, Disney among value stocks deserving a fresh look, Barron's says 12/19/20 Alphabet, Apple among Barron's 10 Top stocks for 2021, Barron's says 12/17/20 Coca-Cola reducing U.S. staff by 12%, cutting 2,200 jobs globally, WSJ reports GM General Motors $56.07 / -0.82 (-1.44%) 02/02/21 'Apple Car' to use E-GMP platform from Hyundai, Apple Insider reports 01/29/21 SoftBank CEO sees mass output of self-driving cars in two years, Reuters says 01/17/21 GM to invest $800M for EV output at Ontario plant, Bloomberg reports 01/14/21 GM planning expansion of Corvette line into SUVs, Bloomberg reports CSCO Cisco $48.44 / -0.49 (-1.00%) 01/19/21 NeoPhotonics speculated as potential takeover target at Dealreporter 01/14/21 Cisco in new deal to acquire Acacia for $115 per share, CNBC reports 01/08/21 Cisco to get order to temporarily stop Acacia ending merger deal, Bloomberg says 01/08/21 Cisco sues Acacia to stop company from breaking merger pact, Bloomberg reports UAL SAVA LYFT KO IQV GMDA GM CSCO AKAM UAL United Airlines $43.32 / -1.03 (-2.32%) 01/21/21 Fly Intel: Wall Street's top stories for Thursday 01/21/21 Fly Intel: Wall Street's top stories at midday 01/20/21 Fly Intel: After-Hours Movers 12/22/20 Fly Intel: Pre-market Movers SAVA Cassava Sciences $57.40 / -3.16 (-5.22%) 11/13/20 Fly Intel: Pre-market Movers 11/12/20 Fly Intel: After-Hours Movers 10/22/20 Fly Intel: After-Hours Movers 09/24/20 Fly Intel: After-Hours Movers LYFT Lyft $53.59 / +0.16 (+0.30%) 02/09/21 Fly Intel: After-Hours Movers 02/09/21 Fly Intel: What to watch in Uber, Lyft earnings reports KO Coca-Cola $49.70 / -0.23 (-0.46%) 02/09/21 Fly Intel: What to watch in Coca-Cola earnings report 01/07/21 Tesla upgrade, Coca-Cola downgrade among today's top calls on Wall Street 01/06/21 Coca-Cola, PepsiCo downgrades among today's top calls on Wall Street 01/04/21 Airbnb, DoorDash coverage initiations among today's top calls on Wall Street IQV Iqvia $184.05 / -2.81 (-1.50%) 10/20/20 Fly Intel: Pre-market Movers GMDA Gamida Cell $9.92 / -0.19 (-1.88%) 12/07/20 Fly Intel: Wall Street's top stories for Monday 12/07/20 Crispr rises following ASH update for genome editing cell therapy candidate 12/07/20 Fly Intel: Wall Street's top stories at midday GM General Motors $56.07 / -0.82 (-1.44%) 02/09/21 Fly Intel: Wall Street's top stories for Tuesday 02/09/21 Fly Intel: Wall Street's top stories at midday 02/06/21 Charged: Apple, Hyundai-Kia said to be close to 'Apple Car' deal 02/04/21 Fly Intel: What to watch in auto sector earnings reports CSCO Cisco $48.44 / -0.49 (-1.00%) 01/14/21 Fly Intel: Wall Street's top stories for Thursday 01/14/21 Fly Intel: Wall Street's top stories at midday 01/08/21 Fly Intel: Wall Street's top stories for Friday AKAM Akamai $118.01 / +0.73 (+0.62%) 12/08/20 Fastly jumps after report of DNS work with Apple 10/27/20 Fly Intel: After-Hours Movers 10/15/20 Fly Intel: Wall Street's top stories at midday 02/11/21 Technology & Internet Virtual Conference 02/10/21 Coca-Cola - KO 02/10/21 Iqvia - IQV 02/10/21 General Motors - GM 03/12/21 ExOne - XONE 02/25/21 Akamai Technologies UAL SAVA LYFT KO GMDA GM ENLV CSCO AKAM UAL United Airlines $43.32 / -1.03 (-2.32%) 02/08/21 United Continental call volume above normal and directionally bullish 01/20/21 United Continental options imply 6.4% move in share price post-earnings 12/16/20 United Continental call volume above normal and directionally bullish 12/10/20 Unusual call flow in option market yesterday SAVA Cassava Sciences $57.40 / -3.16 (-5.22%) 02/03/21 Unusually active option classes on open February 3rd 02/02/21 Cassava Sciences call volume above normal and directionally bullish 09/25/20 Cassava Sciences call volume above normal and directionally bullish 09/18/20 Cassava Sciences call volume above normal and directionally bullish LYFT Lyft $53.59 / +0.16 (+0.30%) 02/09/21 Lyft options imply 13.2% move in share price post-earnings 01/19/21 Lyft call volume above normal and directionally bullish 12/21/20 Lyft put volume heavy and directionally bearish 12/01/20 Lyft call volume above normal and directionally bullish KO Coca-Cola $49.70 / -0.23 (-0.46%) 11/10/20 Coca Cola call volume above normal and directionally bullish 10/30/20 Coca Cola put volume heavy and directionally bearish 10/22/20 Unusually active option classes on open October 22nd 09/02/20 Coca Cola call volume above normal and directionally bullish GMDA Gamida Cell $9.92 / -0.19 (-1.88%) 01/19/21 Nine new option listings and thirteen option delistings on January 19th GM General Motors $56.07 / -0.82 (-1.44%) 01/28/21 General Motors call volume above normal and directionally bullish 01/20/21 Notable open interest changes for January 20th 01/19/21 Early notable gainers among liquid option names on January 19th 01/13/21 Early notable gainers among liquid option names on January 13th ENLV Enlivex Therapeutics $23.90 / +0.85 (+3.69%) 10/12/20 Three new option listings and two option delistings on October 12th CSCO Cisco $48.44 / -0.49 (-1.00%) 02/08/21 Unusually active option classes on open February 8th 02/05/21 Unusually active option classes on open February 5th 02/04/21 Unusually active option classes on open February 4th 01/11/21 Cisco call volume above normal and directionally bullish AKAM Akamai $118.01 / +0.73 (+0.62%) 02/09/21 Akamai options imply 9.0% move in share price post-earnings 01/15/21 Early notable gainers among liquid option names on January 15th 10/26/20 Early notable gainers among liquid option names on October 26th

On The Fly

News and insights, exclusive to thefly.com

09:57	Fly Intel: Top five analyst initiations»
09:57	Fly Intel: Top five analyst downgrades»
09:57	Fly Intel: Top five analyst upgrades»
09:46	Snap rallies after music, Lenses agreement with Universal Music Group»
07:22	Eli Lilly jumps on expedited plans for Alzheimer's drug, Biogen falls»

View all On The Fly Stories »

Upcoming
Events (10)

CVRX	CVRx - CVRX
OLED	Universal Display - OLED
CLVR	Clever Leaves - CLVR
TCOM	Trip.com Group - TCOM
	World Microbe Virtual Forum
BRPHF ...	Real Estate, Mortgage, and Blockchain & Cryptocurrency Virtual Conference
CNXN ...	Virtual Investor Conference
	Policy Virtual Summit 2021
AMZN ...	Virtual ‘Bricks to Clicks’ Digital Conference
	Annual Virtual Meeting of EASL

View all of today’s events »

Today’s
Syndicate (11)

BHG	IPO
CFLT	IPO
DOCS	IPO
GLUE	IPO
MIRO	IPO
SSR	IPO
AFCG	Secondary
BNL	Spot Secondary
OSW	Spot Secondary
PRTG	Spot Secondary
TALO	Spot Secondary

View this week’s syndicate »

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial